CNMD - Company ID 0000816956
The table below shows CONMED Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B | $862.46M |
| Cost of revenue | $624.25M | $573.98M | $568.50M | $474.23M | $442.60M | $402.16M |
| Gross profit | $750.48M | $733.03M | $676.25M | $571.25M | $568.04M | $460.30M |
| R&D | $55.88M | $54.43M | $52.60M | $47.15M | $43.56M | $40.47M |
CONMED Corp reported annual revenue of $1.37B for fiscal year 2025. That is up 5.2% from $1.31B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $763.52M (FY 2016) to $1.37B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $591.97M |
| $478.28M |
| $503.04M |
| $454.04M |
| $414.75M |
| $373.82M |
| Operating income | $102.62M | $200.33M | $120.60M | $70.05M | $109.72M | $46.01M |
| Income tax | $24.06M | $30.61M | $16.37M | $9.72M | $10.56M | -$7.91M |
| Net income | $47.10M | $132.40M | $64.50M | -$80.60M | $62.50M | $9.52M |
| EPS (diluted) | $1.51 | $4.25 | $2.04 | -$2.68 | $1.94 | $0.32 |